Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2008
08/27/2008CN101253151A GPCR agonists
08/27/2008CN101252947A Nutrient composition
08/27/2008CN101252939A Steroidal glycoside compounds as core 2N-glcnac-t inhibitors
08/27/2008CN101252926A Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
08/27/2008CN101250547A Recombinant expression of human desmocyte growth factor-21
08/27/2008CN101250261A Gamma-polyglutamic acid-chromium complexes, preparation and use thereof
08/27/2008CN101250133A Novel method for synthesizing (í‚)p-fluoro-2-(2-methyl-propionyl)-4-oxygen-N,3-diphenyl-benzenebutanamide and intermediate therein
08/27/2008CN101249230A Diabetes medicament and method of preparing the same
08/27/2008CN101249190A Anti-inflammation sterilizing Chinese medicine compound externally used coating liquid and method of preparing the same
08/27/2008CN101249183A Capsules for curing hypertension and condensed blood lipid
08/27/2008CN101249176A Chinese medicine prescription for steaming and soaking foots
08/27/2008CN101249158A Traditional Chinese medicine preparation for preventing and treating cardiovascular and cerebrovascular diseases and preparation
08/27/2008CN101249136A Applications of compound red sage root tablet for pharmacy
08/27/2008CN101249131A Gynostemma pentaphylla soft capsules preparations and method of preparing the same
08/27/2008CN101249129A Chinese medicine extract combination and medicine use thereof
08/27/2008CN101249116A Waxberry polyphenol chromocor extract, and preparations and applications thereof
08/27/2008CN101249112A Fat-reducing products containing black tea Eurotium Cristatum and preparation thereof
08/27/2008CN101249100A Compound formula to supplement protein and manufacture method thereof
08/27/2008CN101249094A Use of synthetic vitamin B1 derivative for preparing ophthalmocace medicament
08/27/2008CN101248876A Norcholesterol health care drink
08/27/2008CN101248871A Lowing blood sugar, blood pressure, blood fat biological food product containing jade substance component
08/27/2008CN101248870A Lowering blood and blood pressure plants extract, preparation and applications thereof
08/27/2008CN100413975C Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product
08/27/2008CN100413884C Process for extracting protein/polypeptide-K from i(momordica charantia), products and use thereof
08/27/2008CN100413876C Epimeridinoside A and epimeredi indica root extract preparation containing same and preparing method therefor
08/27/2008CN100413863C Novel 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/27/2008CN100413862C Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
08/27/2008CN100413860C Piperidine derivative as NMDA receptor antagonist
08/27/2008CN100413852C Valsartan salts
08/27/2008CN100413535C Application of nerve growth factor in preparation of medicine for effective reducing body weight
08/27/2008CN100413521C Health product for reducing blood fat, and preparation method thereof
08/27/2008CN100413512C Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
08/27/2008CN100413511C Method for separating active blood sugar-lowering substances from silkworm powder
08/27/2008CN100413509C Use of lambda-carrageenan oligose in preparing blood vessel proliferation inhibitor
08/27/2008CN100413508C Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol
08/27/2008CN100413507C 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteopenia or male osteoporosis
08/27/2008CN100413425C Diet fiber composition with blood lipid-reducing blood sugar-decreasing functions and its production method
08/26/2008US7417052 Phenylene derivative having tetrazole ring or thiazolidinedione ring
08/26/2008US7417043 3-substituted 4-(phenyl-N-alkyl)-piperazine derivatives; central nervous system disorders; dualistic dopaminergic action profile with antagonist-like effects on brain neurochemistry and mild agonist-like effects on normal behavior, induce inhibition of behavior in hyperactivity; oral bioavailability
08/26/2008US7417039 Use of substituted azetidinone compounds for the treatment of sitosterolemia
08/26/2008US7417038 administering to the patient an effective amount of an agent which reduces sympathetic nervous system activity; a beta receptor blocker or a compound which inhibits the effect of aldosterone
08/26/2008US7417034 Pharmaceutically active uridine esters
08/26/2008US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases
08/26/2008US7417027 For decreasing food intake; eating disorders; sexual disorders
08/26/2008US7416885 Proliferation factor is obtained from the UCHT1 rat thyroid cell line, or a fragment, analogue or derivateve
08/26/2008US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety
08/26/2008US7416849 HBM variants that modulate bone mass and lipid levels
08/26/2008US7416848 DNA encoding SNORF25 receptor
08/26/2008US7416744 Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use
08/26/2008CA2432129C Pyrazole compounds useful as protein kinase inhibitors
08/26/2008CA2429117C Remedy for diabetes mellitus
08/26/2008CA2392165C Vitamin d analogues
08/26/2008CA2347474C Bicyclic nitrogen heterocycles
08/26/2008CA2284909C Medical food for diabetics
08/26/2008CA2277112C Use of exendins and agonists thereof for the reduction of food intake
08/26/2008CA2208981C Novel trienoic retinoid compounds and methods
08/22/2008CA2617688A1 Solid dosage formulations containing weight-loss drugs
08/21/2008WO2008101012A1 Use of ranolazine for the treatment of non-coronary microvascular diseases
08/21/2008WO2008101008A1 Use of ranolazine for the treatment of coronary microvascular diseases
08/21/2008WO2008101002A1 Use of ranolazine for the treatment of cardiovascular diseases
08/21/2008WO2008100627A2 The secreted protein ccdc80 regulates adipocyte differentiation
08/21/2008WO2008100453A1 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
08/21/2008WO2008100220A1 Compositions for increasing body weight, use and methods
08/21/2008WO2008099969A1 Anti-fgf23 antibody and pharmaceutical composition comprising the same
08/21/2008WO2008099913A1 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient
08/21/2008WO2008099804A1 Therapeutic agent for diabetic cataract
08/21/2008WO2008099794A1 Fused ring compounds as partial agonists of ppar-gamma
08/21/2008WO2008099649A1 Appetite suppressive composition
08/21/2008WO2008099448A1 Preventive/therapeutic agent for diabetic diseases
08/21/2008WO2008099423A2 A novel herbal drug and a process for preparation thereof for the prevention and management of endothellal dysfunction among type-ii diabetes mellitus cases
08/21/2008WO2008099221A1 Amide and urea derivatives for the treatment of metabolic diseases
08/21/2008WO2008099145A1 Pyrazole derivatives as 11-beta-hsd1 inhibitors
08/21/2008WO2008099075A1 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors
08/21/2008WO2008099074A1 Phenyl- (4-phenyl-pyrimidin-2-yl) - amine derivatives as ikk inhibitors, preparation thereof, and pharmaceutical compositions thereof
08/21/2008WO2008099073A1 N, n' -2, 4-dianilinopyrimidines preparation and use thereof as ikk inhibitors preparation and teh pharmacuetical compositions thereof
08/21/2008WO2008099025A2 Body-weight maintenance and body composition
08/21/2008WO2008098280A1 Methods for the synthesis of dicarba bridges in growth hormone peptides
08/21/2008WO2008081096A3 Quinolinyl derivatives, method for preparing same, pharmaceutic compositions containing same, and use thereof as hypoglycemiant and hypolipemiant agents
08/21/2008WO2008058127A9 Agonist trkb antibodies and uses thereof
08/21/2008WO2008057855A3 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity
08/21/2008WO2008019143A9 Use of exendins and glp-i receptor agonists for altering lipoprotein particle size and subclass composition
08/21/2008WO2007100695A3 Metabolic regulators and uses thereof
08/21/2008US20080200559 Reducing fat; using ace inhibitor
08/21/2008US20080200527 obesity, metabolic syndrome, Type II diabetes, cardiovascular disease, osteoarthritis, cancers; mental disorders; sexual and/or reproductive dysfunctions, epilepsy; 5-(4-Chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid [3-(1H-tetrazol-5-yl)-propyl]-amide
08/21/2008US20080200521 Novel hydroxamic acid containing amino acid derivatives
08/21/2008US20080200504 non-peptide NK-3 receptor ligands; anxiety, depression, schizophrenia, obesity; 2-Phenyl-quinoline-4-carboxylic acid (1-pyridin-4-yl-propyl) amide; reacting the 2-phenyl-quinolinyl-4-carbonyl chloride with a pyridylalkylamine to form the amide
08/21/2008US20080200502 Methods of lowering lipid levels in a mammal
08/21/2008US20080200501 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone;
08/21/2008US20080200500 Quinoline Derivatives as Nk3 Antagonists
08/21/2008US20080200495 Pyrrolopyridine Compounds, Method of Making Them and Uses Thereof
08/21/2008US20080200494 Imidazopyridine Derivatives
08/21/2008US20080200468 2-Substituted 5-Membered Heteroaryl Carboxylates as Hm74a Receptor Agonists
08/21/2008US20080200467 alpha keto amides and alpha hydroxy amides; N-[3-(3-Morpholin-4-yl-propoxy)-phenyl]-2-oxo-2-(4-trifluoromethyl-phenyl)-acetamide; N-Adamantan-1-yl-2-(3-benzyloxyphenyl)-2-hydroxy-acetamide; hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases
08/21/2008US20080200459 Tetrahydroquinoline cannabinoid receptor modulators
08/21/2008US20080200458 Inhibiting Delta 5-desaturase by contacting Delta 5-desaturase with a compound such as N-(3-chlorophenyl)thieno[3,2-d]pyrimidin-4-amineor a pharmaceutically acceptable salt or solvate thereof; treating, preventing and managing disorders e.g., obesity, diabetes
08/21/2008US20080200456 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine
08/21/2008US20080200454 Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
08/21/2008US20080200447 Neurotherapeutic Compositions and Method
08/21/2008US20080200446 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia
08/21/2008US20080200422 Methods for reduction of adipose tissue mass
1 ... 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 ... 1298